To support this set of results, we exploited an immunocapture-based ELISA assay to quantify and characterise CA IX expression levels in exosomes purified from 1 ml of either PCa or CTR plasma, by seeding the same amount of exosomes preparations (50 μl). This evidence concerns the gene CA9 and posterior cortical atrophy.